Cargando…

Factors associated with augmentation in patients with restless legs syndrome

BACKGROUND AND PURPOSE: Augmentation is a paradoxical reaction mainly to dopaminergic medication in patients with restless legs syndrome (RLS), but the exact pathomechanism remains unclear. The aim of this study was to identify factors associated with augmentation in RLS patients. METHODS: RLS patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Heim, Beatrice, Ellmerer, Philipp, Stefani, Ambra, Bergmann, Melanie, Brandauer, Elisabeth, Seppi, Klaus, Högl, Birgit, Djamshidian, Atbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303546/
https://www.ncbi.nlm.nih.gov/pubmed/34923723
http://dx.doi.org/10.1111/ene.15221
_version_ 1784751892905066496
author Heim, Beatrice
Ellmerer, Philipp
Stefani, Ambra
Bergmann, Melanie
Brandauer, Elisabeth
Seppi, Klaus
Högl, Birgit
Djamshidian, Atbin
author_facet Heim, Beatrice
Ellmerer, Philipp
Stefani, Ambra
Bergmann, Melanie
Brandauer, Elisabeth
Seppi, Klaus
Högl, Birgit
Djamshidian, Atbin
author_sort Heim, Beatrice
collection PubMed
description BACKGROUND AND PURPOSE: Augmentation is a paradoxical reaction mainly to dopaminergic medication in patients with restless legs syndrome (RLS), but the exact pathomechanism remains unclear. The aim of this study was to identify factors associated with augmentation in RLS patients. METHODS: RLS patients with and without current or previous augmentation were recruited. Demographic characteristics, history of smoking, questionnaires for depression, alexithymia, and impulsivity, and RLS severity were obtained. RESULTS: We included 122 patients, of whom half had a history of augmentation. Patients with augmentation had a longer disease duration (p = 0.001), had higher RLS severity scores (p = 0.013), had higher levodopa equivalent doses (p < 0.001), had higher scores for alexithymia (p = 0.028), had higher prevalence of impulse control disorders (p < 0.001), more often had a history of smoking (p = 0.039), were more often currently smoking (p = 0.015), and had more average pack‐years (p = 0.016). CONCLUSIONS: Here, we describe several factors commonly associated with augmentation in RLS. These may help clinicians to screen and treat patients carefully to avoid the challenging side effect of augmentation.
format Online
Article
Text
id pubmed-9303546
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93035462022-07-28 Factors associated with augmentation in patients with restless legs syndrome Heim, Beatrice Ellmerer, Philipp Stefani, Ambra Bergmann, Melanie Brandauer, Elisabeth Seppi, Klaus Högl, Birgit Djamshidian, Atbin Eur J Neurol Movement Disorders BACKGROUND AND PURPOSE: Augmentation is a paradoxical reaction mainly to dopaminergic medication in patients with restless legs syndrome (RLS), but the exact pathomechanism remains unclear. The aim of this study was to identify factors associated with augmentation in RLS patients. METHODS: RLS patients with and without current or previous augmentation were recruited. Demographic characteristics, history of smoking, questionnaires for depression, alexithymia, and impulsivity, and RLS severity were obtained. RESULTS: We included 122 patients, of whom half had a history of augmentation. Patients with augmentation had a longer disease duration (p = 0.001), had higher RLS severity scores (p = 0.013), had higher levodopa equivalent doses (p < 0.001), had higher scores for alexithymia (p = 0.028), had higher prevalence of impulse control disorders (p < 0.001), more often had a history of smoking (p = 0.039), were more often currently smoking (p = 0.015), and had more average pack‐years (p = 0.016). CONCLUSIONS: Here, we describe several factors commonly associated with augmentation in RLS. These may help clinicians to screen and treat patients carefully to avoid the challenging side effect of augmentation. John Wiley and Sons Inc. 2021-12-29 2022-04 /pmc/articles/PMC9303546/ /pubmed/34923723 http://dx.doi.org/10.1111/ene.15221 Text en © 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Movement Disorders
Heim, Beatrice
Ellmerer, Philipp
Stefani, Ambra
Bergmann, Melanie
Brandauer, Elisabeth
Seppi, Klaus
Högl, Birgit
Djamshidian, Atbin
Factors associated with augmentation in patients with restless legs syndrome
title Factors associated with augmentation in patients with restless legs syndrome
title_full Factors associated with augmentation in patients with restless legs syndrome
title_fullStr Factors associated with augmentation in patients with restless legs syndrome
title_full_unstemmed Factors associated with augmentation in patients with restless legs syndrome
title_short Factors associated with augmentation in patients with restless legs syndrome
title_sort factors associated with augmentation in patients with restless legs syndrome
topic Movement Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303546/
https://www.ncbi.nlm.nih.gov/pubmed/34923723
http://dx.doi.org/10.1111/ene.15221
work_keys_str_mv AT heimbeatrice factorsassociatedwithaugmentationinpatientswithrestlesslegssyndrome
AT ellmererphilipp factorsassociatedwithaugmentationinpatientswithrestlesslegssyndrome
AT stefaniambra factorsassociatedwithaugmentationinpatientswithrestlesslegssyndrome
AT bergmannmelanie factorsassociatedwithaugmentationinpatientswithrestlesslegssyndrome
AT brandauerelisabeth factorsassociatedwithaugmentationinpatientswithrestlesslegssyndrome
AT seppiklaus factorsassociatedwithaugmentationinpatientswithrestlesslegssyndrome
AT hoglbirgit factorsassociatedwithaugmentationinpatientswithrestlesslegssyndrome
AT djamshidianatbin factorsassociatedwithaugmentationinpatientswithrestlesslegssyndrome